Progyny, Inc.
PGNY
$20.80
-$0.25-1.19%
| Weiss Ratings | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.57% | |||
| 30-Day Total Return | -5.54% | |||
| 60-Day Total Return | 40.92% | |||
| 90-Day Total Return | 33.76% | |||
| Year to Date Total Return | 17.32% | |||
| 1-Year Total Return | -39.81% | |||
| 2-Year Total Return | -40.45% | |||
| 3-Year Total Return | -52.14% | |||
| 5-Year Total Return | -10.19% | |||
| 52-Week High % Change | -46.00% | |||
| 52-Week Low % Change | 57.21% | |||
| Price | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $38.98 | |||
| 52-Week Low Price | $13.39 | |||
| 52-Week Low Price (Date) | Nov 15, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.80B | |||
| Enterprise Value | 1.59B | |||
| Price/Earnings (TTM) | 37.16 | |||
| Earnings Per Share (TTM) | 0.57 | |||
| Earnings Per Share Growth | -10.12% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.60 | |||
| Price/Book (Q) | 4.22 | |||
| Enterprise Value/Revenue (TTM) | 1.36 | |||
| Price | $20.80 | |||
| Enterprise Value/EBITDA (TTM) | 22.50 | |||
| Enterprise Value/EBIT | 23.56 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 88.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 888 3124 | |||
| Address | 1359 Broadway New York, NY 10018 | |||
| Website | www.progyny.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.77% | |||
| Profit Margin | 4.65% | |||
| Management Effectiveness | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.18% | |||
| Return on Equity | 11.14% | |||
| Income Statement | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.17B | |||
| Total Revenue (TTM) | 1.17B | |||
| Revenue Per Share | $13.13 | |||
| Gross Profit (TTM) | 253.36M | |||
| EBITDA (TTM) | 70.63M | |||
| EBIT (TTM) | 67.46M | |||
| Net Income (TTM) | 54.34M | |||
| Net Income Avl. to Common (TTM) | 54.34M | |||
| Total Revenue Growth (Q YOY) | 10.55% | |||
| Earnings Growth (Q YOY) | -21.81% | |||
| EPS Diluted (TTM) | 0.57 | |||
| EPS Diluted Growth (Q YOY) | -16.96% | |||
| Balance Sheet | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 227.95M | |||
| Cash Per Share (Q) | $2.56 | |||
| Total Current Assets (Q) | 472.72M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 422.06M | |||
| Current Ratio (Q) | 2.803 | |||
| Book Value Per Share (Q) | $4.98 | |||
| Total Assets (Q) | 607.10M | |||
| Total Current Liabilities (Q) | 168.63M | |||
| Total Debt (Q) | 19.27M | |||
| Total Liabilities (Q) | 185.04M | |||
| Total Common Equity (Q) | 422.06M | |||
| Cash Flow | PGNY - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 195.79M | |||
| Cash from Financing (TTM) | -309.88M | |||
| Net Change in Cash (TTM) | 65.02M | |||
| Levered Free Cash Flow (TTM) | 174.58M | |||
| Cash from Operations (TTM) | 179.11M | |||
